Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FTC Prioritizes Food Advertising Investigations Over Supplement Claims

This article was originally published in The Tan Sheet

Executive Summary

Investigations into conventional food claims likely will supplant dietary supplements as an advertising enforcement priority at the Federal Trade Commission, an official says
Advertisement

Related Content

Despite FTC's "Timid" Kellogg Action, Rigorous Claims Enforcement Expected
Despite FTC's "Timid" Kellogg Action, Rigorous Claims Enforcement Expected
Despite FTC's "Timid" Kellogg Action, Rigorous Claims Enforcement Expected
FDA's Flurry Of Food Claim Warnings Sends Bold Enforcement Message
Omega-3 Probe Underscores FTC Standard For Claims Substantiation
FTC Staffing Up To Boost Consumer Health Fraud Enforcement
FTC Staffing Up To Boost Consumer Health Fraud Enforcement
FTC Stakes New Territory, Joins FDA In Warning On H1N1 Claims
FTC Intensifies Health Claims Scrutiny, Enforcement Strategies

Topics

Advertisement
UsernamePublicRestriction

Register

PS104066

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel